APLS Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
APLS Stock 12 Month Forecast
There Are No Analyst Ratings for APLS In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
APLS Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Mizuho Securities
$41.03→$41
Hold
-0.07%
Downside
Reiterated
05/11/26
RBC Capital
$41
Hold
-0.07%
Downside
Reiterated
05/08/26
Roth MKM
$31→$41
Hold
-0.07%
Downside
Downgraded
04/02/26
J.P. Morgan
$37→$41
Hold
-0.07%
Downside
Downgraded
04/01/26
Stifel Nicolaus
$48→$41
Hold
-0.07%
Downside
Downgraded
04/01/26
H.C. Wainwright
$48→$41
Hold
-0.07%
Downside
Downgraded
04/01/26
Raymond James
$45→$41
Hold
-0.07%
Downside
Downgraded
04/01/26
Barclays
$24→$41
Hold
-0.07%
Downside
Assigned
04/01/26
Robert W. Baird
$41
Hold
-0.07%
Downside
Downgraded
04/01/26
Needham
―
Hold
―
Downgraded
03/31/26
Jefferies
$41
Hold
-0.07%
Downside
Downgraded
03/31/26
Citi
$44→$41
Hold
-0.07%
Downside
Downgraded
03/31/26
Morgan Stanley
$25→$41
Hold
-0.07%
Downside
Assigned
03/31/26
TD Cowen
$45→$40
Buy
-2.51%
Downside
Reiterated
02/24/26
Bank of America Securities
$28
Buy
-31.76%
Downside
Reiterated
02/24/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Mizuho Securities
$41.03→$41
Hold
-0.07%
Downside
Reiterated
05/11/26
RBC Capital
$41
Hold
-0.07%
Downside
Reiterated
05/08/26
Roth MKM
$31→$41
Hold
-0.07%
Downside
Downgraded
04/02/26
J.P. Morgan
$37→$41
Hold
-0.07%
Downside
Downgraded
04/01/26
Stifel Nicolaus
$48→$41
Hold
-0.07%
Downside
Downgraded
04/01/26
H.C. Wainwright
$48→$41
Hold
-0.07%
Downside
Downgraded
04/01/26
Raymond James
$45→$41
Hold
-0.07%
Downside
Downgraded
04/01/26
Barclays
$24→$41
Hold
-0.07%
Downside
Assigned
04/01/26
Robert W. Baird
$41
Hold
-0.07%
Downside
Downgraded
04/01/26
Needham
―
Hold
―
Downgraded
03/31/26
Jefferies
$41
Hold
-0.07%
Downside
Downgraded
03/31/26
Citi
$44→$41
Hold
-0.07%
Downside
Downgraded
03/31/26
Morgan Stanley
$25→$41
Hold
-0.07%
Downside
Assigned
03/31/26
TD Cowen
$45→$40
Buy
-2.51%
Downside
Reiterated
02/24/26
Bank of America Securities
$28
Buy
-31.76%
Downside
Reiterated
02/24/26
Best Analysts Covering Apellis Pharmaceuticals
3 Months
Success Rate
14/27 ratings generated profit
Average Return
+4.65%
reiterated a buy rating 5 months ago
Copying Phil Nadeau's trades and holding each position for 3 Months would result in 51.85% of your transactions generating a profit, with an average return of +4.65% per trade.
1 Year
Success Rate
6/22 ratings generated profit
Average Return
-13.99%
reiterated a buy rating 5 months ago
Copying Phil Nadeau's trades and holding each position for 1 Year would result in 27.27% of your transactions generating a profit, with an average return of -13.99% per trade.
2 Years
Success Rate
6/16 ratings generated profit
Average Return
-21.65%
reiterated a buy rating 5 months ago
Copying Phil Nadeau's trades and holding each position for 2 Years would result in 37.50% of your transactions generating a profit, with an average return of -21.65% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
APLS Analyst Recommendation Trends
Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
10
11
12
7
3
Buy
11
13
12
6
3
Hold
17
22
70
79
72
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
38
46
94
92
78
Each month's total comprises the sum of three months' worth of ratings.
APLS Stock Forecast FAQ
What is APLS’s average 12-month price target, according to analysts?
Currently, no data Available
What is APLS’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for APLS, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is APLS a Buy, Sell or Hold?
Currently, no data Available
What is Apellis Pharmaceuticals Inc’s price target?
Currently, no data Available
What do analysts say about Apellis Pharmaceuticals Inc?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of APLS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.